These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24509055)

  • 21. Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder.
    Wigal SB; Childress A; Berry SA; Belden H; Walters F; Chappell P; Sherman N; Orazem J; Palumbo D
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):690-699. PubMed ID: 28557548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-related effect of methylphenidate on stopping and changing in children with attention-deficit/hyperactivity disorder.
    Lijffijt M; Kenemans JL; ter Wal A; Quik EH; Kemner C; Westenberg H; Verbaten MN; van Engeland H
    Eur Psychiatry; 2006 Dec; 21(8):544-7. PubMed ID: 15994064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interactive effects of test-retest and methylphenidate administration on cognitive performance in youth with ADHD: A double-blind placebo-controlled crossover study.
    Horowitz I; Avirame K; Naim-Feil J; Rubinson M; Moses E; Gothelf D; Levit-Binnun N
    Psychiatry Res; 2020 Sep; 291():113056. PubMed ID: 32554183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
    Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
    CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
    Rubia K; Halari R; Mohammad AM; Taylor E; Brammer M
    Biol Psychiatry; 2011 Aug; 70(3):255-62. PubMed ID: 21664605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting.
    Silva R; Muniz R; Pestreich LK; Brams M; Childress A; Lopez FA
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):637-54. PubMed ID: 16190795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder.
    Childress AC; Kollins SH; Foehl HC; Newcorn JH; Mattingly G; Kupper RJ; Adjei AL
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):58-68. PubMed ID: 32125903
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of a skipped dose (placebo) of methylphenidate on the learning and retention of a motor skill in adolescents with Attention Deficit Hyperactivity Disorder.
    Fox O; Adi-Japha E; Karni A
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):391-6. PubMed ID: 24332892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of methylphenidate on sustained attention among adolescents with attention-deficit hyperactivity disorder.
    Lufi D; Bassin-Savion S; Rubel L
    Neurocase; 2015; 21(6):802-8. PubMed ID: 25771849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.
    Kubas HA; Backenson EM; Wilcox G; Piercy JC; Hale JB
    Postgrad Med; 2012 Sep; 124(5):33-48. PubMed ID: 23095424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder.
    Arnold LE; Lindsay RL; Conners CK; Wigal SB; Levine AJ; Johnson DE; West SA; Sangal RB; Bohan TP; Zeldis JB
    J Child Adolesc Psychopharmacol; 2004; 14(4):542-54. PubMed ID: 15662146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder.
    Günther T; Herpertz-Dahlmann B; Konrad K
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):179-86. PubMed ID: 20578930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status.
    Huang YS; Wang LJ; Chen CK
    BMC Psychiatry; 2012 Nov; 12():194. PubMed ID: 23140464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
    Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
    CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHD.
    Kim Y; Shin MS; Kim JW; Yoo HJ; Cho SC; Kim BN
    Hum Psychopharmacol; 2009 Mar; 24(2):95-102. PubMed ID: 19226534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
    Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
    Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylphenidate restores link between stop-signal sensory impact and successful stopping in adults with attention-deficit/hyperactivity disorder.
    Overtoom CC; Bekker EM; van der Molen MW; Verbaten MN; Kooij JJ; Buitelaar JK; Kenemans JL
    Biol Psychiatry; 2009 Apr; 65(7):614-9. PubMed ID: 19103443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD?
    Boonstra AM; Kooij JJ; Oosterlaan J; Sergeant JA; Buitelaar JK
    J Clin Exp Neuropsychol; 2005 Apr; 27(3):278-98. PubMed ID: 15969353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.